Skip to main content
. 2021 Apr 17;13(4):569. doi: 10.3390/pharmaceutics13040569
5GG Pentagalloylglucose
ABCSG Austrian breast and colorectal cancer study group
AC Adenocarcinoma
c-AMP Cyclic adenosine monophosphate
CCND1 Cyclin D1
CDC2 kinase Cell division control 2 kinase
CDKs Cyclin-dependent kinases
CI Confidence interval
DC Ductal carcinoma
DCIS Ductal carcinoma in situ
DFS Disease-free survival
DSS Disease-specific survival
E2F1 E2 promoter factor 1
ER Estrogen receptor
FISH Fluorescent in situ hybridization
GLOBOCAN Global cancer observatory
HDAC3 Histone deacetylase 3
HER2+ Human epidermal growth factor receptor2+
HR Hazard ratio
IDC Invasive ductal carcinoma
IHC Immunohistochemistry
ILC Invasive lobular carcinoma
LA Luminal A
MU Mutation
NBE Normal breast epithelium
ND Not decided
OS Overall survival
PD Proliferative disease
PR Progesterone receptor
Rb Retinoblastoma
RFS Recurrence free survival
siRNA Small interfering RNA
TGF-β Transforming growth factor-β
TNBC Triple negative breast cancer
WT Wild type